CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Cadre Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$27.07+0.69 (+2.62%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 33.4
- Dividend yield
- 1.40%
Cadre Holdings, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $621.52M | $571.62M | $543.71M | $545.57M | $503.28M | $491.57M | $497.62M | $449.48M | $461.48M | $436.42M | $410.83M | $412.54M | 90.6% | +23.5% |
| Distribution | $98.93M | $97.34M | $104.90M | $113.64M | $104.99M | $105.07M | $105.40M | $99.39M | $105.76M | $105.90M | $102.37M | $97.86M | 14.4% | -5.8% |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $474.88M | $465.21M | $461.41M | $490.13M | $465.15M | $454.02M | $455.22M | $404.61M | $413.56M | $402.58M | $385.47M | $380.60M | 69.3% | +2.1% |
| International | $210.77M | $170.43M | $148.90M | $128.94M | $107.46M | $105.79M | $112.34M | $111.56M | $118.31M | $106.06M | $97.06M | $101.00M | 30.7% | +96.1% |
From the segment and revenue-disaggregation notes of Cadre's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.